Bansal Nisha, Fan Dongjie, Hsu Chi-Yuan, Ordonez Juan D, Go Alan S
Division of Nephrology, University of Washington, Seattle, WA (N.B.).
Division of Research, Kaiser Permanente Northern California, Oakland, CA (D.F., A.S.G.).
J Am Heart Assoc. 2014 Oct 20;3(5):e001303. doi: 10.1161/JAHA.114.001303.
Atrial fibrillation (AF) frequently occurs in patients with chronic kidney disease (CKD); however, the long-term impact of development of AF on the risk of death among patients with CKD is unknown.
We studied adults with CKD (glomerular filtration rate <60 mL/min per 1.73 m(2) by the Chronic Kidney Disease Epidemiology Collaboration equation) identified between 2002 and 2010 who were enrolled in Kaiser Permanente Northern California and had no previously documented AF. Incident AF was identified using primary hospital discharge diagnoses or ≥2 outpatient visits for AF. Death was comprehensively ascertained from health plan administrative databases, Social Security Administration vital status files, and the California death certificate registry. Covariates included demographics, comorbidity, ambulatory blood pressure, laboratory values (hemoglobin, proteinuria), and longitudinal medication use. Among 81 088 adults with CKD, 6269 (7.7%) developed clinically recognized incident AF during a mean follow-up of 4.8±2.7 years. There were 2388 cases of death that occurred after incident AF (145 per 1000 person-years) compared with 18 865 cases of death during periods without AF (51 per 1000 person-years, P<0.001). After adjustment for potential confounders, incident AF was associated with a 66% increase in relative rate of death (adjusted hazard ratio 1.66, 95% CI 1.57 to 1.77).
Incident AF is independently associated with an increased risk of death in adults with CKD. Further study is needed to understand the mechanisms by which CKD is associated with AF and to identify potentially modifiable risk factors to decrease the burden of AF and subsequent risk of death in this high-risk population.
心房颤动(AF)在慢性肾脏病(CKD)患者中频繁发生;然而,AF的发生对CKD患者死亡风险的长期影响尚不清楚。
我们研究了2002年至2010年间在北加利福尼亚凯撒医疗集团登记的、肾小球滤过率根据慢性肾脏病流行病学合作公式计算<60 ml/(min·1.73 m²)且既往无AF记录的成年CKD患者。新发AF通过主要医院出院诊断或≥2次AF门诊就诊来确定。死亡情况通过健康计划管理数据库、社会保障管理局生命状态档案和加利福尼亚死亡证书登记处全面确定。协变量包括人口统计学、合并症、动态血压、实验室检查值(血红蛋白、蛋白尿)和纵向用药情况。在81088例成年CKD患者中,6269例(7.7%)在平均4.8±2.7年的随访期间发生了临床确诊的新发AF。AF发生后有2388例死亡(每1000人年145例),而在无AF期间有18865例死亡(每1000人年51例,P<0.001)。在对潜在混杂因素进行调整后,新发AF与死亡相对风险增加66%相关(调整后风险比1.66, 95%CI 1.57至1.77)。
新发AF与成年CKD患者死亡风险增加独立相关。需要进一步研究以了解CKD与AF相关的机制,并确定潜在的可改变风险因素,以减轻AF负担及降低该高危人群随后的死亡风险。